Inventor · disambiguated record
Donald G. Musson
Also filed as: MUSSON DONALD G
9 granted patents·3 pending applications·84 citations·filing 1989–2023
89Inventor score
Top patents by PatentIndex Score
12 records- 0196US11060128B2Methods of administering 3,4-diaminopyridineSERB SA·Filed 2020·Granted Jul 13, 2021·6 cites·28 claims
- 0295US11274332B2Methods of administering 3,4-diaminopyridineSERB SA·Filed 2021·Granted Mar 15, 2022·3 cites·26 claims
- 0395US11274331B2Methods of administering 3,4-diaminopyridineSERB SA·Filed 2021·Granted Mar 15, 2022·2 cites·28 claims
- 0495US11268128B2Methods of administering 3,4-diaminopyridineSERB SA·Filed 2021·Granted Mar 8, 2022·3 cites·17 claims
- 0594US11873525B2Methods of administering 3,4-diaminopridineSERB SA·Filed 2023·Granted Jan 16, 2024·1 cites·29 claims
- 0694US11845977B2Methods of administering 3,4-diaminopridineSERB SA·Filed 2023·Granted Dec 19, 2023·1 cites·24 claims
- 0789US10793893B2Methods of administering 3,4-diaminopyridineGAROVOY MARVIN R·Filed 2012·Granted Oct 6, 2020·9 cites·15 claims
- 0879US2023034700A1Methods of Administering 3,4-DiaminopyridineSERB SA·Filed 2022·Application pending·0 cites
- 0975US5290781AKetaneserinol as an agent to reduce intraocular pressureIOLAB CORP·Filed 1993·Granted Mar 1, 1994·47 cites·6 claims
- 1075US2021002693A1Methods of Administering 3,4-DiaminopyridineSERB SA·Filed 2020·Application pending·0 cites
- 1175US2021002694A1Methods of Administering 3,4-DiaminopyridineSERB SA·Filed 2020·Application pending·0 cites
- 1248US5182270AStabilizing preparation for thymoxamineIOLAB CORP·Filed 1989·Granted Jan 26, 1993·12 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Donald G. Musson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →